Atorvia Analysis: $255M Raised
What is Atorvia?
Atorvia develops targeted therapeutics aimed at preventing and treating organ failure, with a primary focus on kidney health. The company utilizes insights from the human proteome and advanced AI models to create novel treatment options for patients lacking effective therapies. Their research addresses the significant health complications associated with kidney failure, including the need for dialysis and related diseases.
Location
SpinUp Lab, University of Toronto at Mississauga, Mississauga, Ontario K2K 3E7, Canada
Employees
1-10
Founded
2021
Funding Status
Seed
Product Features & Capabilities
- Novel therapeutics for kidney failure
- AI models for proteomic analysis
- Research on organ failure prevention
Use Cases
Develop targeted treatments for kidney failure patients; Utilize AI to analyze human proteome; Address health complications from kidney failure; Create therapies for patients requiring dialysis; Research into preventing organ failure
HQ Full Address
SpinUp Lab, University of Toronto at Mississauga, Mississauga, Ontario K2K 3E7, Canada
See something that needs updating? Suggest edits to this profile.